The Wang Lab at the Division of Hematology & Oncology, Columbia University Irving Medical Center, studies how dysregulation of RNA splicing and modifications drives the development and progression of B cell malignancies, with a focus on chronic lymphocytic leukemia (CLL). Using integrative multi-omics approaches and patient-derived models, we aim to uncover how abnormal RNA regulation reshapes gene expression, tumor–microenvironment interactions, and therapeutic responses. Our goal is to translate mechanistic insights into clinically actionable biomarkers and treatment strategies for patients with B cell cancers.
News
- Oct 2026: Ilana presents at the Vagelos College of Physicians and Scientists Frontiers in Research Symposium!
- Oct 2026: The Wang Lab goes on our NYC sightseeing outing!
- Sep 2026: Xiaojie presents at our Leukemia Translational Research Meeting!
- Sep 2026: Erica is granted her NIH NCI F31 Pre-doctoral Fellowship!